Alebund Pharmaceuticals
Clinical trials sponsored by Alebund Pharmaceuticals, explained in plain language.
-
New pill tested for slowing diabetic kidney damage
Disease control Recruiting nowThis is an early-stage study to check the safety and how the body processes a new oral drug called AP303 in people with diabetic kidney disease. It will involve 18 participants who will take the drug or a placebo pill for two weeks. The main goal is to see how safe the drug is an…
Phase: PHASE1 • Sponsor: Alebund Pharmaceuticals • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New drug trial aims to tame dangerous mineral in dialysis patients
Disease control Recruiting nowThis study is testing whether a new drug called AP301 can safely lower high phosphate levels in the blood of people on long-term dialysis. Researchers will compare AP301 to a low-dose version in about 264 patients over 32 weeks to see which works better at controlling phosphate a…
Phase: PHASE3 • Sponsor: Alebund Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC